CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 66.67%

Compliant submissions 2

Incompliant submissions 1

Total trials 3

My Organizations' Clinical Trials

Showing 675 of 1308 entries

View as:

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Phase: N/A Priority: Normal

NCT ID: NCT06240351 Org: User:

Start: 04/22/24 End: 07/31/27 Due: 07/31/28

Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula

Phase: N/A Priority: Normal

NCT ID: NCT02414204 Org: User:

Start: 04/30/15 End: 06/30/18 Due: 06/30/19

Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

Phase: N/A Priority: Normal

NCT ID: NCT00334945 Org: User:

Start: 04/30/06 End: 08/31/11 Due: 08/31/12

The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction

Phase: N/A Priority: Normal

NCT ID: NCT00919347 Org: User:

Start: 06/30/09 End: 05/31/10 Due: 05/31/11

Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section

Phase: N/A Priority: Normal

NCT ID: NCT03098420 Org: User:

Start: 07/31/16 End: 05/20/21 Due: 05/20/22

Kangaroo Mother Care With Plastic Bag (Trials 2A & 2B)

Phase: N/A Priority: Normal

NCT ID: NCT03141723 Org: User:

Start: 05/19/17 End: 08/12/17 Due: 08/12/18

Longitudinal Study of Dental Implant Therapy in HIV Positive Patients

Phase: N/A Priority: Normal

NCT ID: NCT01211288 Org: User:

Start: 05/31/10 End: 05/01/20 Due: 05/01/21

EUS-FNA With and Without Suction

Phase: N/A Priority: Normal

NCT ID: NCT02072915 Org: User:

Start: 01/31/14 End: 05/31/14 Due: 05/31/15

Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants

Phase: N/A Priority: Normal

NCT ID: NCT02799875 Org: User:

Start: 12/31/15 End: 04/30/21 Due: 04/30/22

Tissue Partitioning in Early Childhood

Phase: N/A Priority: Normal

NCT ID: NCT01041794 Org: User:

Start: 12/31/09 End: 06/30/11 Due: 06/30/12

ADAPT-Altering Diet for African American Populations to Treat Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00621569 Org: User:

Start: 01/31/05 End: 12/31/11 Due: 12/31/12

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

Phase: N/A Priority: Normal

NCT ID: NCT01070121 Org: User:

Start: 02/28/10 End: 08/31/12 Due: 08/31/13

Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient

Phase: N/A Priority: Normal

NCT ID: NCT01277250 Org: User:

Start: 07/31/11 End: 11/30/14 Due: 11/30/15

The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia

Phase: N/A Priority: Normal

NCT ID: NCT04171323 Org: User:

Start: 03/03/20 End: 08/31/27 Due: 08/31/28

Assessment of Influence of Vitamin D on Insulin Secretion and Sensitivity in Obese Teenage Girls

Phase: N/A Priority: Normal

NCT ID: NCT00851396 Org: User:

Start: 04/30/08 End: 10/31/10 Due: 10/31/11

CA-125 in Screening Patients at High Risk for Ovarian Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00080639 Org: User:

Start: 06/30/03 End: 06/30/07 Due: 06/30/08

An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)

Phase: N/A Priority: Normal

NCT ID: NCT00721565 Org: User:

Start: 04/30/06 End: 08/31/08 Due: 08/31/09

A Phase II Study of Spinal Radiosurgery

Phase: N/A Priority: Normal

NCT ID: NCT00573872 Org: User:

Start: 04/30/05 End: 09/30/16 Due: 09/30/17

Molecular Mechanisms of Mitral Regurgitation-Aim 2

Phase: N/A Priority: Normal

NCT ID: NCT01052532 Org: User:

Start: 06/30/05 End: 11/30/10 Due: 11/30/11

Oxygen Insufflation in Microlaryngoscopies

Phase: N/A Priority: Normal

NCT ID: NCT04979533 Org: User:

Start: 01/01/23 End: 05/30/23 Due: 05/30/24

The Effect of TRA-8 on Ovarian Cancer Tissue

Phase: N/A Priority: Normal

NCT ID: NCT00711932 Org: User:

Start: 08/31/08 End: 01/31/13 Due: 01/31/14

Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT02372253 Org: User:

Start: 02/28/15 End: 12/31/19 Due: 12/31/20

Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

Phase: N/A Priority: Normal

NCT ID: NCT03442101 Org: User:

Start: 04/01/18 End: 12/31/24 Due: 12/31/25

Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)

Phase: N/A Priority: Normal

NCT ID: NCT04795856 Org: User:

Start: 06/30/27 End: 08/31/28 Due: 08/31/29

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06173310 Org: User:

Start: 10/10/24 End: 03/31/29 Due: 03/31/30

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)	NCT06240351	University of Alabama at Birmingham	user2@example.com	None	2024-04-22	2027-07-31	2028-07-31	-	-	2025-07-14
Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula	NCT02414204	University of Alabama at Birmingham	user2@example.com	None	2015-04-30	2018-06-30	2019-06-30	-	-	2025-07-14
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent	NCT00334945	University of Alabama at Birmingham	user2@example.com	None	2006-04-30	2011-08-31	2012-08-31	-	-	2025-07-14
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction	NCT00919347	University of Alabama at Birmingham	user2@example.com	None	2009-06-30	2010-05-31	2011-05-31	-	-	2025-07-14
Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section	NCT03098420	University of Alabama at Birmingham	user2@example.com	None	2016-07-31	2021-05-20	2022-05-20	-	-	2025-07-14
Kangaroo Mother Care With Plastic Bag (Trials 2A & 2B)	NCT03141723	University of Alabama at Birmingham	user2@example.com	None	2017-05-19	2017-08-12	2018-08-12	-	-	2025-07-14
Longitudinal Study of Dental Implant Therapy in HIV Positive Patients	NCT01211288	University of Alabama at Birmingham	user2@example.com	None	2010-05-31	2020-05-01	2021-05-01	-	-	2025-07-14
EUS-FNA With and Without Suction	NCT02072915	University of Alabama at Birmingham	user2@example.com	None	2014-01-31	2014-05-31	2015-05-31	-	-	2025-07-14
Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants	NCT02799875	University of Alabama at Birmingham	user2@example.com	None	2015-12-31	2021-04-30	2022-04-30	-	-	2025-07-14
Tissue Partitioning in Early Childhood	NCT01041794	University of Alabama at Birmingham	user2@example.com	None	2009-12-31	2011-06-30	2012-06-30	-	-	2025-07-14
ADAPT-Altering Diet for African American Populations to Treat Hypertension	NCT00621569	University of Alabama at Birmingham	user2@example.com	None	2005-01-31	2011-12-31	2012-12-31	-	-	2025-07-14
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository	NCT01070121	University of Alabama at Birmingham	user2@example.com	None	2010-02-28	2012-08-31	2013-08-31	-	-	2025-07-14
Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient	NCT01277250	University of Alabama at Birmingham	user2@example.com	None	2011-07-31	2014-11-30	2015-11-30	-	-	2025-07-14
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia	NCT04171323	University of Alabama at Birmingham	user2@example.com	None	2020-03-03	2027-08-31	2028-08-31	-	-	2025-07-14
Assessment of Influence of Vitamin D on Insulin Secretion and Sensitivity in Obese Teenage Girls	NCT00851396	University of Alabama at Birmingham	user2@example.com	None	2008-04-30	2010-10-31	2011-10-31	-	-	2025-07-14
CA-125 in Screening Patients at High Risk for Ovarian Cancer	NCT00080639	University of Alabama at Birmingham	user2@example.com	None	2003-06-30	2007-06-30	2008-06-30	-	-	2025-07-14
An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)	NCT00721565	University of Alabama at Birmingham	user2@example.com	None	2006-04-30	2008-08-31	2009-08-31	-	-	2025-07-14
A Phase II Study of Spinal Radiosurgery	NCT00573872	University of Alabama at Birmingham	user2@example.com	None	2005-04-30	2016-09-30	2017-09-30	-	-	2025-07-14
Molecular Mechanisms of Mitral Regurgitation-Aim 2	NCT01052532	University of Alabama at Birmingham	user2@example.com	None	2005-06-30	2010-11-30	2011-11-30	-	-	2025-07-14
Oxygen Insufflation in Microlaryngoscopies	NCT04979533	University of Alabama at Birmingham	user2@example.com	None	2023-01-01	2023-05-30	2024-05-30	-	-	2025-07-14
The Effect of TRA-8 on Ovarian Cancer Tissue	NCT00711932	University of Alabama at Birmingham	user2@example.com	None	2008-08-31	2013-01-31	2014-01-31	-	-	2025-07-14
Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes	NCT02372253	University of Alabama at Birmingham	user2@example.com	None	2015-02-28	2019-12-31	2020-12-31	-	-	2025-07-14
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study	NCT03442101	University of Alabama at Birmingham	user2@example.com	None	2018-04-01	2024-12-31	2025-12-31	-	-	2025-07-14
Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)	NCT04795856	University of Alabama at Birmingham	user2@example.com	None	2027-06-30	2028-08-31	2029-08-31	-	-	2025-07-14
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer	NCT06173310	University of Alabama at Birmingham	user2@example.com	None	2024-10-10	2029-03-31	2030-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance